Prophylactic surgery in non-cirrhotic portal fibrosis:is it worthwhile?

Indian J Gastroenterol. 2005 Nov-Dec;24(6):239-42.

Abstract

Background: In cirrhotic patients with portal hypertension prophylactic portasystemic shunts have been found to be ineffective as deaths from post-shunt liver failure exceed those from bleeding. However, in patients with non-cirrhotic portal hypertension, variceal bleeding rather than liver failure is the common cause of death. In developing countries shortage of tertiary health-care facilities and blood banks further increases mortality due to variceal bleed.

Aim: To study the results of prophylactic operations to prevent variceal bleeding in patients with portal hypertension due to non-cirrhotic portal fibrosis (NCPF).

Methods: Between 1976 and 2001, we performed 45 prophylactic operations in patients with NCPF, if the patients had high-risk esophagogastric varices or symptomatic splenomegaly and hypersplenism. Proximal lienorenal shunt was done in 41 patients and the remaining underwent splenectomy with (2 patients) or without (2 patients) devascularization.

Results: There was no operative mortality. Thirty-eight patients were followed up for a mean 49 (range, 12-236) months. Three patients bled - one was variceal and two due to duodenal ulcers; none died of bleeding. There were 2 late deaths (6 weeks and 10 years after surgery), one from an unknown cause and one due to chronic renal failure. The delayed morbidity was 47%. This included 7 patients who developed portasystemic encephalopathy, 4 glomerulonephritis, 2 pulmonary arteriovenous fistulae and 5 ascites requiring treatment with diuretics. Thus only 20 (53%) patients were symptom-free on follow up.

Conclusions: Prophylactic surgery is safe and effective in preventing variceal bleeding in NCPF but at the cost of high delayed morbidity.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Esophageal and Gastric Varices / prevention & control*
  • Female
  • Fibrosis
  • Gastrointestinal Hemorrhage / prevention & control*
  • Humans
  • Hypertension, Portal / surgery*
  • Male
  • Middle Aged
  • Portal Vein / pathology*
  • Portal Vein / surgery*
  • Portasystemic Shunt, Surgical*
  • Postoperative Complications